Skip to main content

Table 6 Multiple logistic regression derived odds ratios (and 95% Confidence Intervals) for the association between sample characteristics and immunization with all 3 newer vaccines (MenC, PCV7, Var)

From: Immunization coverage and predictive factors for complete and age-appropriate vaccination among preschoolers in Athens, Greece: a cross- sectional study

  Complete immunization (n=731) Age appropriate immunization at
12 months (n=731) 24 months (n=704)
  OR (95% CI) p OR (95% CI) p OR (95% CI) p
Actual age 0.77 (0.65-0.91) 0.002 0.47 (0.35-0.64) <0.001 0.45 (0.29-0.71) 0.001
Father’s nationality
Other Reference
Greek 1.29 (0.88-1.90) 0.188 2.10(0.91-4.86) 0.082 2.95 (0.91-9.50) 0.071
Number of children
1 Reference
2 0.91 (0.64-1.31) 0.621 0.58 (0.31-1.09) 0.092 0.41 (0.19-0.90) 0.026
3+ 0.77 (0.48-1.22) 0.265 0.42 (0.18-1.01) 0.053 0.27 (0.08-0.89) 0.031
Maternal education
≤12 years Reference
>13 years 0.73 (0.53-1.02) 0.061 0.68 (0.38-1.22) 0.198 0.42 (0.19-0.94) 0.035
Use of multivalent vaccines
≤ 4-valent Reference
5- or 6-valent 1.09 (0.78-1.50) 0.630 3.46 (1.51-7.92) 0.003 2.24 (0.88-5.68) 0.090
Impact of insurance reimbursement on the decision to vaccinate
No Reference
Yes 0.95 (0.67-1.34) 0.764 1.22 (0.65-2.28) 0.538 1.28 (0.57-2.90) 0.551
Place of vaccination
Privately Reference
Insurance clinic / Public health clinic 1.39 (0.95-2.03) 0.086 0.64 (0.32-1.30) 0.216 0.56 (0.23-1.36) 0.199
Type of insurance
IKA Reference
Other 1.13 (0.77-1.66) 0.545 1.67 (0.84-3.34) 0.144 1.69 (0.70-4.11) 0.244
  1. Men C: conjugated meningococcal C vaccine; PCV7: conjugated pneumococcal 7-valent vaccine; Var: varicella vaccine.
  2. IKA: Social Security Institute.